Sciact
  • EN
  • RU

The Crystal Structure Elucidation of a Tetrapeptide Analog of Somatostatin DOTA-Phe-D-Trp-Lys-Thr-OMe Научная публикация

Журнал Crystals
, E-ISSN: 2073-4352
Вых. Данные Год: 2022, Том: 12, Номер: 1, Номер статьи : 12, Страниц : 11 DOI: 10.3390/cryst12010012
Ключевые слова XRD; analogue; somatostatin; DOTA; PRRT
Авторы Diusenova Sabina 1,2 , Arkhipov Sergey 2,3,4 , Avdeev Dmitry 5 , Dorovatovskii Pavel 6 , Khachatryan Derenik 7 , Lazarenko Vladimir 6 , Medvedev Michael 8 , Nikolaeva Alena 6 , Ovchinnikov Mikhail 5 , Sidorova Maria 5 , Zubavichus Yan 4
Организации
1 Boreskov Institute of Catalysis SB RAS, 630090 Novosibirsk, Russia
2 Faculty of Natural Sciences, Department of Solid State Chemistry, Novosibirsk State University, 630090 Novosibirsk, Russia
3 State Research Center of Virology and Biotechnology VECTOR of the Federal Service for Surveillance in Consumer Rights Protection and Human Well-being (FSRI SRC VB VECTOR), 630559 Koltsovo, Russia
4 Synchrotron Radiation Facility SKIF, G.K. Boreskov Institute of Catalysis SB RAS, 630559 Koltsovo, Russia
5 National Medical Research Center for Cardiology, Ministry of Health of the Russian Federation, 121552 Moscow, Russia
6 National Research Center, Kurchatov Institute, 123189 Moscow, Russia
7 Institute for Chemical Reagents and High Purity Chemical Substances of NRC, 107076 Moscow, Russia;
8 N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 119991 Moscow, Russia

Информация о финансировании (2)

1 Министерство науки и высшего образования Российской Федерации (с 15 мая 2018) ГЗ-2021-2023
2 Министерство науки и высшего образования Российской Федерации (с 15 мая 2018) 075-15-2021-1355 (121120100401-9)

Реферат: Herewith, we report for the first time the crystal structure of tetrapeptide FwKT (Phe-D-Trp-Lys-Thr), which is considered to represent an epitope for biomedically relevant hormone somatostatin. The target molecule was successfully crystalized, solved and refined as a conjugate of the tetrapeptide moiety bearing a protective group DOTA at the N-terminus and methylated at the O-terminus. The combination of a hormone active site and a powerful chelator make the substance a highly prospective targeted drug delivery system, especially for peptide receptor radionuclide therapy (PRRT) applications.
Библиографическая ссылка: Diusenova S. , Arkhipov S. , Avdeev D. , Dorovatovskii P. , Khachatryan D. , Lazarenko V. , Medvedev M. , Nikolaeva A. , Ovchinnikov M. , Sidorova M. , Zubavichus Y.
The Crystal Structure Elucidation of a Tetrapeptide Analog of Somatostatin DOTA-Phe-D-Trp-Lys-Thr-OMe
Crystals. 2022. V.12. N1. 12 :1-11. DOI: 10.3390/cryst12010012 WOS Scopus РИНЦ CAPlus OpenAlex СКИФ ID
Даты:
Поступила в редакцию: 17 нояб. 2021 г.
Принята к публикации: 16 дек. 2021 г.
Опубликована online: 22 дек. 2021 г.
Опубликована в печати: 1 янв. 2022 г.
Идентификаторы БД:
Web of science: WOS:000758173200001
Scopus: 2-s2.0-85121751393
РИНЦ: 47549257
Chemical Abstracts: 2022:216285
OpenAlex: W4200335960
СКИФ ID: 508
Цитирование в БД:
БД Цитирований
Scopus 1
РИНЦ 1
Web of science 1
OpenAlex 1
Альметрики: